ABI

60.58

+1.44%↑

CDI

450.2

+1.99%↑

DG

132.1

+3.2%↑

AD

41.2

+2.51%↑

HEIO

62.8

+2.7%↑

ABI

60.58

+1.44%↑

CDI

450.2

+1.99%↑

DG

132.1

+3.2%↑

AD

41.2

+2.51%↑

HEIO

62.8

+2.7%↑

ABI

60.58

+1.44%↑

CDI

450.2

+1.99%↑

DG

132.1

+3.2%↑

AD

41.2

+2.51%↑

HEIO

62.8

+2.7%↑

ABI

60.58

+1.44%↑

CDI

450.2

+1.99%↑

DG

132.1

+3.2%↑

AD

41.2

+2.51%↑

HEIO

62.8

+2.7%↑

ABI

60.58

+1.44%↑

CDI

450.2

+1.99%↑

DG

132.1

+3.2%↑

AD

41.2

+2.51%↑

HEIO

62.8

+2.7%↑

Search

Bonduelle SCA

Fermé

8.62 1.77

Résumé

Variation du prix de l'action

24h

Actuel

Min

8.31

Max

8.68

Chiffres clés

By Trading Economics

Revenu

-6.4M

Ventes

27M

1.1B

P/E

Moyenne du Secteur

12.254

27.787

Rendement du dividende

3.05

Marge bénéficiaire

-0.594

Employés

7,625

EBITDA

1.1B

51M

Recommandations

By TipRanks

Recommandations

Vente

Prévisions sur 12 Mois

-5.1% downside

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

3.05%

3.82%

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-63M

263M

Ouverture précédente

6.85

Clôture précédente

8.62

Score Technique

By Trading Central

Confiance

Very Strong Bearish Evidence

Bonduelle SCA Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

31 mars 2026, 23:31 UTC

Actions en Tendance

Stocks to Watch: Nike, RH, NCino

31 mars 2026, 22:35 UTC

Résultats

Nike Guides for Sales Declines Ahead as Turnaround Plan Hits Snags -- 2nd Update

1 avr. 2026, 00:00 UTC

Acquisitions, Fusions, Rachats

The Year Is Off to the Strongest Start for Big Deals Ever -- WSJ

31 mars 2026, 23:50 UTC

Acquisitions, Fusions, Rachats

Nxera Pharma: Partner Centessa Pharmaceuticals to Be Acquired by Lilly >LLY 4565.TO

31 mars 2026, 23:43 UTC

Market Talk

Nikkei May Rise on Hopes for Iran War Ending Soon -- Market Talk

31 mars 2026, 23:33 UTC

Market Talk
Principaux Événements d'Actualité

Gold Edges Higher on Signs of De-Escalating Middle East Tensions -- Market Talk

31 mars 2026, 23:21 UTC

Résultats

Nike Stock Slides on Tariff Impact Despite Earnings Beat; Turnaround Continues -- Barrons.com

31 mars 2026, 23:14 UTC

Market Talk
Résultats

Nike CEO Says Turnaround is Taking Longer Than He'd Like -- Market Talk

31 mars 2026, 23:12 UTC

Market Talk

Aurelia's Cash Flow Strength Highlighted by New Financing Deal -- Market Talk

31 mars 2026, 22:36 UTC

Résultats

China Vanke 2025 Loss Widens >000002.SZ

31 mars 2026, 22:36 UTC

Résultats

China Vanke: Increase in Inventory Impariment Provision Among Factors Weighing On Results>000002.SZ

31 mars 2026, 22:36 UTC

Résultats

China Vanke 2025 Loss CNY88.56B Vs. Loss CNY49.48B >000002.SZ

31 mars 2026, 22:36 UTC

Résultats

China Vanke: Will Take Time to Resolve Issues Caused by High Debt Levels>000002.SZ

31 mars 2026, 22:36 UTC

Résultats

China Vanke 2025 Rev CNY233.43B Vs. CNY343.18B >000002.SZ

31 mars 2026, 21:46 UTC

Acquisitions, Fusions, Rachats

Big Drug Companies Hunting for Deals Are Lowering Their Sights -- WSJ

31 mars 2026, 21:36 UTC

Market Talk

West African Resources's Costs Higher Than Bull Expected -- Market Talk

31 mars 2026, 21:35 UTC

Résultats

Nike Expects China Sales Down 20% in 4Q, CFO Says

31 mars 2026, 21:35 UTC

Résultats

Nike Expects Modest Growth in North America, Offset by Declines in China, Converse Brand in 4Q, CFO Says

31 mars 2026, 21:35 UTC

Résultats

Nike Forecasts 4Q Sales Down 2% to 4%, CFO Says

31 mars 2026, 21:33 UTC

Acquisitions, Fusions, Rachats

Biotechs Are a Healthy Growth Bet Thanks to M&A and New Drugs -- Barrons.com

31 mars 2026, 21:33 UTC

Résultats

Nike Expects Sales Down Low-Single Digits From Now Through End of Calendar Year, CFO Says

31 mars 2026, 21:32 UTC

Résultats

Nike Expects 1Q to Be Final Quarter Where Tariffs Continue to Be Year-Over-Year Headwind to Margins, CFO Says

31 mars 2026, 21:28 UTC

Résultats

Nike Expects to End 4Q With Elevated Inventory, CFO Says

31 mars 2026, 21:26 UTC

Résultats

Nike Increasingly Confident It Will Return to Balanced Growth in North America in Direct, Wholesale Channels, CFO Says

31 mars 2026, 21:25 UTC

Résultats

Nike Expects Supply-Chain Changes to Pay Off Starting in Fiscal 2027, CFO Says

31 mars 2026, 21:24 UTC

Market Talk
Résultats

Nike: Turnaround Plan Progressing at Different Rates -- Market Talk

31 mars 2026, 21:22 UTC

Résultats

Nike CFO Expects Football Training and Basketball Will Return to Growth Over Next Few Quarters

31 mars 2026, 21:22 UTC

Résultats

Nike's Sportswear Business Declined Low-Double Digits in 3Q, CFO Says

31 mars 2026, 21:21 UTC

Résultats

Nike's Digital Channel Still Too Promotional, CFO Says

31 mars 2026, 21:20 UTC

Résultats

Nike CEO: Converse Remains Important to Portfolio

Comparaison

Variation de prix

Bonduelle SCA prévision

Objectif de Prix

By TipRanks

-5.1% baisse

Prévisions sur 12 Mois

Moyen 8 EUR  -5.1%

Haut 8 EUR

Bas 8 EUR

Basé sur 1 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Vente

1 ratings

0

Achat

0

Maintien

1

Vente

Score Technique

By Trading Central

7.53 / 8.3Support & Résistance

Court Terme

Very Strong Bearish Evidence

Moyen Terme

Weak Bearish Evidence

Long Terme

Bullish Evidence

Éléments financiers

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Bonduelle SCA

Bonduelle SCA produces, processes, and sells vegetables in Europe and internationally. The company offers canned, frozen, ready-to-use vegetables; and pulses, fruits, and aromatics. It provides its products under the Bonduelle, Cassegrain, Globus, and Ready Pac Foods brands. The company was founded in 1853 and is headquartered in Renescure, France.
help-icon Live chat